150
Participants
Start Date
December 18, 2024
Primary Completion Date
June 5, 2026
Study Completion Date
June 5, 2026
Eptinezumab
Solution for infusion
RECRUITING
Albany Medical College, Albany
RECRUITING
Dent Neurosciences Research Center, Inc., Amherst
RECRUITING
Preferred Primary Care Physicians, Inc., Pittsburgh
RECRUITING
Thomas Jefferson University, Philadelphia
RECRUITING
PANDA Neurology and Atlanta Headache Specialists, Atlanta
RECRUITING
Brainstorm Research, Miami
RECRUITING
Premiere Research Institute at Palm Beach Neurology, West Palm Beach
RECRUITING
KCA Neurology, PLLC, Franklin
RECRUITING
C7 Research, Cleveland
RECRUITING
NeuroScience Research Center, LLC., Canton
RECRUITING
Memorial Healthcare, Owosso
RECRUITING
Chicago Headache Center & Research Institute, Chicago
RECRUITING
Crescent City Headache and Neurology, New Orleans
RECRUITING
Research of the Rockies, Parker
RECRUITING
Advanced Neurology of Colorado, LLC, Longmont
RECRUITING
St Luke's Meridian Medical Center, Meridian
RECRUITING
The Neuron Clinic, San Marcos
RECRUITING
Neuropain Medical Center, Fresno
RECRUITING
Sunwise Clinical Research, LLC., Oakland
RECRUITING
New England Institute for Neurology and Headache, Stamford
RECRUITING
MedVadis Research Corporation, Watertown
RECRUITING
Texas Neurology, PA, Dallas
H. Lundbeck A/S
INDUSTRY